期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

低分子肝素对长期维持性血液透析患者血脂的影响

下载PDF
导出
摘要 目的:调查低分子肝素(lowmolecularweightheparin ,LMWH)对维持性血液透析患者血脂代谢的影响。方法:采用对照分析方法,分析血液透析患者长期应用LMWH和普通肝素(unfractionaledheparin ,UFH)抗凝对血脂的影响。结果:将普通UFH改为LMWH (吉派林)抗凝,治疗6月、12月、18月时,血液透析患者血清总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)胆固醇与治疗前均无统计学差异,与UFH组相比,也无统计学差异。结论:长期用某些LMWH抗凝,血液透析患者脂质代谢紊乱并不能得到改善。
作者 刘毅 郑尘飞 许菲菲 徐玉兰
机构地区 温州医学院第一附属医院肾内科
出处 《中国中西医结合肾病杂志》 2005年第4期226-227,共2页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 低分子肝素 血液透析 血脂 脂代谢 尿毒症
分类号 R692.5 [医药卫生—泌尿科学]
  • 相关文献

参考文献8

  • 1Shoji T,Nishizawa Y,Nishitani H,et al.Impaired metabolism of high density lipoprotein in uremic patients.Kidney Int,1992,41(6):1653-1661.
  • 2Akiba T,Tachibana K,Ozawa K,et al.Long-term use of low molecular weight heparin ameliorates hyperlipidemia in patients on hemodialysis.ASAIO J,1992,38(3):326-330.
  • 3Stefoni S,Cianciolo G,Donati G,et al.Standard heparin versus low-molecular-weight heparin.A medium-term comparison in hemodialysis.Nephron,2002,92(3):589-600.
  • 4Lai KN,Ho K,Cheung RC,et al.Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis.Int J Artif Organs,2001,24(7):447-455.
  • 5郭彦聪,张凌.低分子肝素对血液透析患者脂代谢影响的回顾性分析[J].中国血液净化,2003,2(6):311-314. 被引量：11
  • 6Kronenberg F,Konig P,Neyer U,et al.Influence of various heparin preparations ln liporoteins in hemodialysis patients:a multicentre study.Thromb Haemost,1995,74(4):1025-1028.
  • 7Kronenberg F,Konig P,Lhotta K,et al.Low molecular weight heparin does not necessarily reduce lipids and liporoteins in hemodialysis patients.Clin Nephrol,1995,43(6):399-404.
  • 8Josehson MA,Fellner SK,Dasgupta A.Improved lipid profiles in patients undergoing high-flux hemodialysis.Am J Kid Dis,1992,20(4):361-366.

二级参考文献12

  • 1[1]Arnadottir M,Kurkus J,Nilsson EP. Different types of heparin in hemeodialysis: long term effects on post-heparin lipases. Scard J Clin Lab Invest,1994,54:515-521
  • 2[2]Bergvist D.Low molecular weight heparins.J Intern Med ,1996,240:63-72
  • 3[3]Stefoni S, Cianciolo G, Donati G et al. Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis. Nephron, 2002,92(3):589-600
  • 4[4]Lai KN, Ho K, Cheung RC et al. Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis. Int J Artif Organs, 2001, 24(7):447-55
  • 5[5]Stenvinkel P.Low molecular weight heparin:Does it favourably affect lipid levels?Nephrol Dial Transplant,1995,19:16
  • 6[6]Weintraub M,Rassin T,Eisenberg S, et al.Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation.J Lipid Res,1994,35:229
  • 7[7]Yang C,Wu T,Huang C,et al.Low molecular weight heparin reduces triglyceride,VLDL and cholesterol/HDL levels in hyperlipidemic diabetic patients on hemodialysis.Am J Nephrol,1998,18(5):384
  • 8[8]Elisaf MS,Germanos NP,Bairaktari HT,et al.Effects of conventional vs low-molecularweight heparin on lipid profil in hemodialysis patients.Am J Nephrol,1997,17(2):153
  • 9[9]Kronenberg F,Konig P,Neyer U,et al.Influence of various heparin preparation on lipoproteins in hemodialysis patients:a multicentre study.Thromb Haemost,1995,74(4):1025
  • 10[10]Kronenberg F,Konig Pm,Lhotta K,et al.Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.Clin Nephrol,1995,43:399

共引文献10

中国中西医结合肾病杂志
2005年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部